Recent developments in the use of antidepressant and anxiolytic medications.
In this article the authors review recent research contributions to the knowledge regarding the role of antidepressant and anxiolytic medications in the treatment of child psychiatry disorders. For each of the two classes of drug, recent data regarding a range of indications are evaluated. In addition, general methodologic issues and future research priorities are discussed.
Simeon
J G
JG
Ferguson
H B
HB
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy*; D001010:Anxiety, Separation / Q000188:drug therapy; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D001569:Benzodiazepines; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy; D003866:Depressive Disorder / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004775:Enuresis / Q000188:drug therapy; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy; D010698:Phobic Disorders / Q000188:drug therapy; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D001569:Benzodiazepines